Yet one year on, there is a vast disparity in access to COVID-19 medical products between the high-income countries and low-middle-income countries.
![](https://wp.greenwatchbd.com/wp-content/uploads/2017/02/IPR-2.jpg)
Yet one year on, there is a vast disparity in access to COVID-19 medical products between the high-income countries and low-middle-income countries.